ODX2 Jun 2020 18:45
If you haven’t seen it -
May 1, 2020 08:00 UTC
OXFORD, England & BURLINGTON, Mass.--(BUSINESS WIRE)-- Blue Earth Diagnostics, a Bracco company focused on molecular imaging diagnostics, today announced that its CEO, Dr Jonathan Allis, has been appointed as Chair of the UK Rapid Testing Consortium (UK-RTC) for COVID-19 by the UK Department of Health and Social Care (DHSC). The UK-RTC has been formed to draw upon the expertise and resources of the UK’s life sciences industries in a combined effort to design and develop a home use antibody test to determine whether people have developed antibodies (and perhaps, potential immunity) after contracting and recovering from COVID-19. It combines the science of Oxford University with the development and manufacturing skills of four UK diagnostic companies: Abingdon Health in England, BBI Solutions in Wales, Omega Diagnostics in Scotland and CIGA Healthcare in Northern Ireland. In his role as Chair of the UK-RTC, Dr Allis will serve as an independent liaison between the participating diagnostic companies and the government. The part-time engagement is of a limited duration, during which time Dr Allis will retain his responsibilities as CEO of Blue Earth Diagnostics. The UK-RTC Chair is independent of the diagnostic companies involved, and Blue Earth Diagnostics is not otherwise engaged in this initiative.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200501005100/en/
Jonathan Allis, CEO of Blue Earth Diagnostics (Photo: Business Wire)
Jonathan Allis, CEO of Blue Earth Diagnostics (Photo: Business Wire)
“When the DHSC invited me to chair a consortium to develop a COVID-19 antibody test based on new technology developed at Oxford University, and in light of the urgency of the COVID-19 health crisis worldwide, I felt it was my absolute duty to say ‘yes,’” said Jonathan Allis, D. Phil, CEO of Blue Earth Diagnostics. “Testing for the presence of the SARS-CoV-2 virus (antigen testing) and immune response after COVID-19 (antibody testing) is possible in large hospital and public and private labs now, but what we really need is a home test (somewhat similar to a home pregnancy test), which can be used to test the whole population. This would help us understand how much of the population has been exposed to the virus and help determine plans for people getting back to work.”